Published in Cancer on November 01, 1975
The use of naturally occurring cancer in domestic animals for research into human cancer: general considerations and a review of canine skeletal osteosarcoma. Yale J Biol Med (1979) 0.82
Virus-induced animal model of osteosarcoma in the rat: Morphologic and biochemical studies. Am J Pathol (1977) 0.79
Field evaluation of Thayer-Martin medium for identification of meningococcus carriers. Am J Epidemiol (1965) 4.06
Immunofluorescence techniques for demonstrating bacterial pathogens associated with cerebrospinal meningitis. 3. Identification of meningococci from the nasopharynx of asymptomatic carriers. Am J Epidemiol (1966) 3.72
A curriculum for the ideal orthopaedic residency. Academic Orthopaedic Society. Clin Orthop Relat Res (1997) 1.94
Activation of suppressor T cells by tumour cells and specific antibody. Nature (1974) 1.67
On the mode of action of BCG. Nat New Biol (1973) 1.47
Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes. Invest Ophthalmol Vis Sci (1989) 1.44
A general journal in a specialized world. Yale J Biol Med (1976) 1.39
Activation of lymphoid cells by BCG in vitro. Cell Immunol (1975) 1.38
2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion. Spine (Phila Pa 1976) (2001) 1.35
Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg Am (1984) 1.30
Effects of freezing and freeze-drying on the biomechanical properties of rat bone. J Orthop Res (1984) 1.27
Atypical decubital fibroplasia. A distinctive fibroblastic pseudotumor occurring in debilitated patients. Am J Surg Pathol (1992) 1.25
Angiosarcoma associated with foreign body material. A report of three cases. Cancer (1988) 1.24
Pulmonary manifestations in Behçet syndrome. Case report and review of the literature. Arch Intern Med (1976) 1.23
The N-terminal ATPase site in the large terminase protein gp17 is critically required for DNA packaging in bacteriophage T4. J Mol Biol (2001) 1.20
Bone grafts. The basic science rationale for clinical applications. J Bone Joint Surg Am (1987) 1.19
Immunosuppressive effects of cytosine arabinoside and methotrexate in man. Ann Intern Med (1969) 1.14
Biomechanical properties of bone allografts. Clin Orthop Relat Res (1983) 1.12
Immune responses to osteochondral allografts. Current knowledge and future directions. Clin Orthop Relat Res (1983) 1.12
Antigen-antibody complexes generate Lyt 1 inducers of suppressor cells. J Immunol (1980) 1.11
The influence of ibuprofen on fracture repair: biomechanical, biochemical, histologic, and histomorphometric parameters in rats. J Orthop Res (1991) 1.08
Systemic bacillus Calmette-Guérin (BCG) activates natural suppressor cells. Proc Natl Acad Sci U S A (1978) 1.06
Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide. Int J Cancer (1998) 1.01
Improved therapeutic index of methotrexate with "leucovorin rescue". Cancer Res (1973) 0.99
Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. Cancer Res (1984) 0.99
The effect of radiation on the fracture repair process. A biomechanical evaluation of a closed fracture in a rat model. J Orthop Res (1989) 0.98
Immunosuppressive therapy for the eye changes of Graves' disease. J Clin Endocrinol Metab (1970) 0.97
Postfracture irradiation effects on the biomechanical and histologic parameters of fracture healing. J Orthop Res (1991) 0.97
The Nicolas Andry Award-1995. Fracture healing. Radiation induced alterations. Clin Orthop Relat Res (1997) 0.97
Methods of banking bone and cartilage for allograft transplantation. Orthop Clin North Am (1987) 0.97
Studies on the immunogical effects of BCG and its components: theoritical and therapeutic implications. Biomedicine (1976) 0.95
Immunological responses to L-asparaginase. J Clin Invest (1971) 0.94
Case report: clinical findings and successful resection of melanoma metastatic to the right atrium. Cancer Invest (1994) 0.94
Immunologic responses in human recipients of osseous and osteochondral allografts. Clin Orthop Relat Res (1996) 0.93
Bone allografts: the biological consequences of immunological events. J Bone Joint Surg Am (1991) 0.93
Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck. Cancer Res (1968) 0.93
Structural evidence for distinct IgG subclass-specific Fc receptors on mouse peritoneal macrophages. J Exp Med (1980) 0.92
Radiation-induced alterations of fracture healing biomechanics. J Orthop Res (1984) 0.91
Studies on the antigenicity of bone. I. Freeze-dried and deep-frozen bone allografts in rabbits. J Bone Joint Surg Am (1976) 0.91
1983 bone bank procedures. Clin Orthop Relat Res (1983) 0.90
Effects of chemotherapeutic agents on the immune response. I. Cancer Invest (1984) 0.90
The production of tolerance to human erythrocytes in the rat with cytosine arabinoside or cyclophosphamide. J Immunol (1969) 0.90
Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients. Cancer Immunol Immunother (1991) 0.90
Suppressor T cells induced by soluble immune complexes can adoptively transfer inhibition of cytophilic antibody receptors on macrophages. Cell Immunol (1979) 0.90
Monoclonal antibody T101 in T cell malignancies: a clinical, pharmacokinetic, and immunologic correlation. Blood (1986) 0.89
Bone-banking. J Bone Joint Surg Am (1982) 0.89
Human monoclonal antibodies directed against melanoma tumor-associated antigens. Cancer Res (1986) 0.88
Induction of specific T-cell responsiveness to allogeneic bone. J Bone Joint Surg Am (1991) 0.88
Synthetic insertion signal sequences enhance MHC class I presentation of a peptide from the melanoma antigen MART-1. Eur J Immunol (2000) 0.88
Effect of imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno) on immunity in patients with malignant melanoma. Cancer Res (1974) 0.87
Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma. Cancer Immunol Immunother (1993) 0.86
Immunosuppression by 5-fluorouracil. Cancer (1970) 0.86
Studies on the antigenicity of bone. II. Donor-specific anti-HLA antibodies in human recipients of freeze-dried allografts. J Bone Joint Surg Am (1984) 0.85
Osteogenic protein-1 overcomes the inhibitory effect of nicotine on posterolateral lumbar fusion. Spine (Phila Pa 1976) (2001) 0.85
Specific in vivo inhibition of macrophage receptors for cytophilic antibody by soluble immune complexes. Cancer Res (1979) 0.84
The effect of bioburden on in-depth disinfection of denture base acrylic resin. J Calif Dent Assoc (1998) 0.84
Bone graft and total hip arthroplasty. A review. J Arthroplasty (1992) 0.84
Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin. Cancer (1978) 0.84
Immunologic aspects of bone transplantation. A rationale for future studies. Orthop Clin North Am (1987) 0.84
Intratumoral Bacillus Calmette-Guérin immunotherapy prior to surgery for carcinoma of the lung: results of a prospective randomized trial. Cancer Res (1986) 0.84
Biomechanical aspects of bone autografts and allografts. Orthop Clin North Am (1987) 0.83
Immunological aspects of intrinsic glial tumors. J Neurosurg (1981) 0.83
Immunological enhancement of leukemia L1210 by Corynebacterium parvum in allogeneic mice. Cancer Res (1976) 0.83
Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro. Cancer Res (1990) 0.83
Three-dimensional load-displacement curves due to forces on the cervical spine. J Orthop Res (1986) 0.83
Modulation of the immune response by BCG: a review. Yale J Biol Med (1976) 0.82
Cytophilic antibodies in man. Ann Intern Med (1973) 0.82
Clinical evaluation of freeze-dried bone allografts in periodontal osseous defects--part II. J Periodontol (1978) 0.82
Orthopaedic manifestations of sickle-cell disease. Yale J Biol Med (1990) 0.82
Effects of prefracture irradiation on the biomechanical parameters of fracture healing. J Orthop Res (1993) 0.82
Cancer vaccines: novel approaches and new promise. Pharmacol Ther (1999) 0.82
Cell-mediated immunity and blocking factor in ovarian carcinoma. Obstet Gynecol (1976) 0.82
Immunological effects of recombinant interferon-alpha 2 in cancer patients. J Biol Response Mod (1983) 0.82
Effects of chemotherapeutic agents on the immune response. II. Cancer Invest (1985) 0.81
Role of "suppressor" T lymphocytes in antibody-induced inhibition of cytophilic antibody receptors. Ann N Y Acad Sci (1976) 0.81
Non-fastidious, melanoma-specific CD8+ cytotoxic T lymphocytes from choroidal melanoma patients. Cancer Immunol Immunother (1994) 0.81
Fatigue in patients with cancer receiving interferon alpha. Cancer Pract (1995) 0.81
The immune response: the efferent arm. Clin Orthop Relat Res (1996) 0.81
Allograft incorporation: a biomechanical evaluation in a rat model. J Orthop Res (1989) 0.81
Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administration. J Clin Oncol (1987) 0.81
Bone banking: current methods and suggested guidelines. Instr Course Lect (1981) 0.81
Cystic chondroblastoma. Orthopedics (1997) 0.80
Modulation of immunity by bacillus Calmette-Guérin (BCG). Pharmacol Ther (1979) 0.80
Lung carcinoma after radiotherapy and chemotherapy for Hodgkin's disease. Thorax (1977) 0.80
Immunogenicity of xenogeneic cartilage matrix components in a rabbit model. Yale J Biol Med (1984) 0.80
The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group, (SWOG-8921). Am J Clin Oncol (1996) 0.80
Development of a combination chemotherapy program for adult acute leukemia: CAM and CAM-L. Cancer (1973) 0.80
Transplantation of osteochondral allografts. Annu Rev Med (1984) 0.79
Combination sequential chemotherapy in advanced reticulum cell sarcoma. Cancer (1972) 0.79
Personnel and equipment required for a "complete" tissue bank. Transplant Proc (1976) 0.79
Effects of short-term cyclosporin-A on biomechanical properties of intact and fractured bone in the rat. J Orthop Res (1985) 0.79
Novel gene sequences expressed by human melanoma cells identified by molecular subtraction. Cancer Res (1991) 0.79
Failure of bleomycin to affect humoral or cell-mediated immunity in the mouse. Cancer Res (1974) 0.79
Selectivity in the effects of indomethacin on BCG-activated suppressor cell populations. J Immunopharmacol (1981) 0.79
Immunotherapy with bacterial endotoxins. Adv Exp Med Biol (1990) 0.79
Avascular necrosis of bone in Hodgkin's disease patients treated with combined modality therapy. Cancer (1981) 0.78
Active specific immunotherapy of metastatic melanoma with an antiidiotype vaccine: a phase I/II trial of I-Mel-2 plus SAF-m. J Clin Oncol (1997) 0.78
Assignment of a human melanoma associated gene MG50 (D2S448) to chromosome 2p25.3 by fluorescence in situ hybridization. Genomics (1994) 0.78
Chemotherapy-induced alterations in the biomechanics of rat bone. J Orthop Res (1985) 0.78
Studies on the relationship of human natural killer and lymphokine-activated killer cells with lysosomal staining and analysis of surface marker phenotypes. Cell Immunol (1988) 0.78